Emtrix exhibits mechanism of action in which visible improvements are seen within 2-4 weeks of treatment.
Under the agreement OzHealth Pharma will receive rights to market and sell Emtrix in Australia and New Zealand.
Moberg Derma develops patented topical pharmaceuticals for the treatment of common disorders through the use of drug delivery.